Fumarate treatment in progressive forms of multiple sclerosis: first results of a single-center observational study
Conclusion:
Our pilot data indicate that fumarate therapy appears to be safe and well tolerated by patients with progressive MS. In more than 75% of cases no further disease progression was evident. However, controlled studies are warranted to evaluate the detailed therapeutic potential of fumarates and their long-term effects in progressive MS.
Source: Therapeutic Advances in Neurological Disorders - Category: Neurology Authors: Strassburger-Krogias, K., Ellrichmann, G., Krogias, C., Altmeyer, P., Chan, A., Gold, R. Tags: Original Research Source Type: research
More News: Disability | Laboratory Medicine | Medical Ethics | Multiple Sclerosis | Neurology | Psoriasis | Study